Drug Information

Drug General Information
Drug ID
D0C9RZ
Former ID
DIB009368
Drug Name
BU-4601A
Synonyms
BU-4601B; BU-4601C
Drug Type
Small molecular drug
Indication Asthma [ICD10:J45] Terminated [545892]
Company
Bristol-Myers Squibb Co
Formula
C17H27NO3
Canonical SMILES
c1(C(=O)OCCCCCCCC(C)C)c(ccc(c1)O)N
CAS Number
CAS 148915-76-8
PubChem Compound ID
192421
Target and Pathway
Target(s) Arachidonate 5-lipoxygenase Target Info Inhibitor [534063]
BioCyc Pathway Aspirin-triggered lipoxin biosynthesis
Resolvin D biosynthesis
Leukotriene biosynthesis
Lipoxin biosynthesis
Aspirin triggered resolvin D biosynthesis
Aspirin triggered resolvin E biosynthesis
KEGG Pathway Arachidonic acid metabolism
Metabolic pathways
Serotonergic synapse
Ovarian steroidogenesis
Toxoplasmosis
NetPath Pathway IL4 Signaling Pathway
PathWhiz Pathway Arachidonic Acid Metabolism
WikiPathways Vitamin D Receptor Pathway
Arachidonic acid metabolism
Eicosanoid Synthesis
Selenium Micronutrient Network
References
Ref 545892Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800005261)
Ref 5340635-Hydroxyanthranilic acid derivatives as potent 5-lipoxygenase inhibitors. J Antibiot (Tokyo). 1993 May;46(5):705-11.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.